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The study was approved by the institutional 
bioethical committee and all patients’ guard­
ians gave their informed consent.
Statistical analysis was performed using 
the Wizard Pro version 1.9.33 (Evan Miller, Chi­
cago, Illinois, United States). Continuous vari­
ables are presented as mean (SD) or median 
(range) depending on the distribution. The χ2 
test, Pearson correlations, and Spearman rank 
correlations were employed.
Results and discussion Out of 79 screened 
patients, 41 were enrolled after applying inclu­
sion and exclusion criteria and were successful­
ly examined using CMR. They were all men  at 
a mean (SD) age of 12 (3.1) years. A total of 37 
patients (90.2%) had DMD, and 4 (9.8%) had 
BMD. The mean (SD) left ventricular (LV) end­
­diastolic volume index was 63.6 (17.4) ml/m2 
and was decreased in 24% of patients.7 The mean 
(SD) LV end ­systolic volume index (LVESVI) 
was 30 (9) ml/m2 and was abnormally high 
in 12% and abnormally low in 2% of patients. 
The mean (SD) LV stroke volume index (LVSVI) 
was 37 (10.8) ml/m2 and was abnormally low 
in 39% of patients. The mean (SD) LV ejection 
fraction (LVEF) was 58% (6.4%) and was low in 
44% of patients. Older patients had significant­
ly lower LV end­diastolic volume index z score 
(r = –0.41, P = 0.008; FIGURE 1A) but not LVESVI 
Introduction Cardiac magnetic resonance 
(CMR) provides means for tissue characteriza­
tion and has been used in different populations 
to assess global and regional functions, pres­
ence of edema, inflammation, necrosis, and fi­
brosis of the heart chambers.1‑4 Early cardiac in­
volvement can be shown in CMR when standard 
cardiovascular workup including 12­lead elec­
trocardiography, 24­hour electrocardiography, 
and echocardiography are normal ­appearing.5 
The early identification of cardiac involvement 
in patients with Duchenne muscular dystrophy 
(DMD) is important as it allows for a timely in­
troduction of cardioprotective therapy to slow 
down the progression of heart failure and to 
reduce symptoms.6 Based on scarce data from 
limited cohort studies, it is the fibrosis that is 
the most frequent and relevant abnormality 
evolving throughout patients’ lifetime.
The aim of the study was to characterize cardi­
ac involvement in patients of all age groups with 
DMD and Becker muscular dystrophy (BMD).
Methods We present a single center cross­
­sectional observational study of the patients 
representing the DMD population from the en­
tire country.
Inclusion and exclusion criteria as well as de­
tailed CMR diagnostic procedure and protocol 
are presented in Supplementary material.
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 FIGURE 1 The scatter plots show the correlations of left ventricular (LV) volume–related parameters with age: end ‑diastolic 
volume (A), end ‑systolic volume (B), stroke volume (C), and LV ejection fraction (LVEF; D). The bar charts represent the prevalence of 
abnormalities found in different age groups: decreased (<55%) left ventricle ejection fraction (E), and patients with at least 
1 segment positive for late gadolinium enhancement (LGE) (F).
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LVEF in patients with muscular dystrophy were 
previously studied by a number of authors.11,12 In 
a study by Brunklaus et al,12 extensive but not 
minimal LGE was associated with reduced LVEF 
(48% vs 58%, respectively), suggesting more 
severe cardiomyopathy.12 Our study confirms 
the correlation between the presence of any fi­
brosis and decrease in LVEF. However, the cardi­
ac function may be preserved for many years in 
DMD, even with fibrosis progression.11,13 More­
over, whether LGE extent at baseline predicts 
the speed of cardiac function impairment over 
the following years warrants further investiga­
tion. Given the limitations of physical activity 
with age in DMD, the affected individuals may 
not display clinical symptoms unless they are 
exposed to additional stress.14
Finally, all the dot plots also show a notice­
able variability among the patients, (also of 
similar age), suggesting an uneven cardiac in­
volvement in patients. This observation pro­
vides the basis for further longitudinal stud­
ies in the search for CMR parameters allowing 
for risk stratification and treatment escalation 
for those at risk.
In conclusion, in patients with muscular dys­
trophy, fibrosis advances with age and is related 
with impaired LV function. Cardiac magnetic res­
onance provides a detailed insight in chamber 
volumes, myocardial function, and tissue char­
acterization, all of which allow for the detection 
of subtle subclinical cardiac involvement. There­
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z score (P = 0.16; FIGURE 1B). Consequently, also neg­
atively correlated with age were LVSVI z score 
(r = –0.50, P <0.001; FIGURE 1C) and LVEF (r = –0.36, 
P = 0.02; FIGURE 1D). Also, the prevalence of patients 
with decreased LVSVI (Supplementary mate­
rial, Figure S1A), and decreased LVEF (FIGURE 1E) 
was higher in older age groups (P = 0.001 and 
P = 0.04, respectively).
Late gadolinium enhancement (LGE) was as­
sessed in 39 patients and was positive in 38% of 
them, most often in the midanterolateral (38%), 
basal ­anterolateral (36%), basal ­inferolateral 
(31%), mid ­inferolateral (26%), and apical ­lateral 
(18%) segments (Supplementary material, Figure 
S2). In 2 patients, LGE images were deemed non­
diagnostic due to massive respiratory artifacts. 
LGE was significantly more prevalent in the old­
er age groups (P = 0.02; FIGURE 1F). Also, the fibro­
sis extensiveness correlated positively with age 
(r = 0.036, P = 0.02; Supplementary material, Fig‑
ure S1B). Noticeably, no LGE was found in any 
of patients with BMD. The patients with posi­
tive LGE had significantly lower LVSVI z score 
(mean [SD], –2.3 [1.0] vs –1.3 [1.1]; P = 0.02) and 
LVEF (53.2 [5.5] vs 59.5 [5.3]; P <0.001). Fur­
thermore, the extent of fibrosis, irrespective 
of its pattern, correlated with decreased LVEF 
(P < 0.001, r = –0.531; Supplementary material, 
Figure S1C). More detailed data can be found in 
Supplementary material (Tables S1‑S4).
Our study presents preliminary cross­
­sectional data from a Polish cohort of patients 
with DMD and BMD. In line with the previous­
ly published data,8,9 in patients with DMD, we 
were able to show that LGE of the LV myocardi­
um is associated with reduced LVEF. Moreover, 
our study confirmed that the extent of cardiac 
involvement increases with the disease progres­
sion resulting from advancing age, as previous­
ly demonstrated.10 It is known that in DMD and 
BMD, myocardial necrosis starts from the pos­
terobasal region of the left ventricle, progress­
ing to other cardiac segments and leading to 
heart remodeling, which is partly in line with 
our findings, where posterobasal and basal an­
terolateral regions of the LV were commonly 
involved, including the patients with LGE of 
lesser extent.
Contrary to the previously published stud­
ies that suggested LV dilatation coupled with 
the reduction of LVEF,10 our findings showed 
decreased end ­diastolic volumes with preserved 
end ­systolic volumes, resulting in decreased 
stroke volume and LVEF, a pattern of involve­
ment distinct from other cardiomyopathies. En­
largement of the LV was not noted as the study 
described young population in an early stage 
of the disease whereas LV dilatation and overt 
heart failure tends to develop in the third de­
cade of life in the majority of cases.
The presence, extent, and distribution of LGE 
and its relation to LV function as assessed by 
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